New York — US cannabis companies are racing to build national brands and market their wares to mainstream consumers. There is just one problem: it is hard to advertise your product when the federal government considers you a drug dealer. Facebook, which like Google prohibits marijuana ads, has kicked some weed sellers off Instagram. Earlier in January CBS declined to air a commercial touting the benefits of medical marijuana during the Super Bowl. Much the way banks are unwilling to finance cannabis startups, television networks and online advertising marketplaces are understandably cautious because the Feds still classify marijuana as a schedule 1 drug alongside heroin and ecstasy. With a growing number of states legalising cannabis for recreational and medical purposes, the US market could surge eight-fold to $80bn in sales by 2030, according to Cowen & Company. But it is hard to see that happening unless companies can market their wares the way beer and liquor companies do. After...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now